Eye injections may stop blindness before it starts in High-Risk patients

NCT ID NCT02462889

First seen Nov 15, 2025 · Last updated May 03, 2026 · Updated 23 times

Summary

This study tested whether regular eye injections of a drug called aflibercept could prevent the 'wet' form of age-related macular degeneration (AMD) in people already at high risk. 128 participants with early signs of AMD in one eye and wet AMD in the other eye were randomly assigned to receive either the drug or a sham injection. The main goal was to see if the drug could stop the high-risk eye from developing wet AMD over two years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • NJ Retina

    Edison, New Jersey, 08817, United States

  • Ophthalmic Consultants of Boston

    Boston, Massachusetts, 02114, United States

  • Retina Consultants of Houston

    Houston, Texas, 77030, United States

  • Retina-Vitreous Associates Medical Group

    Beverly Hills, California, 90211, United States

Conditions

Explore the condition pages connected to this study.